KR20040025919A - 외용 투여용 올로파타딘 제제 - Google Patents
외용 투여용 올로파타딘 제제 Download PDFInfo
- Publication number
- KR20040025919A KR20040025919A KR10-2003-7014821A KR20037014821A KR20040025919A KR 20040025919 A KR20040025919 A KR 20040025919A KR 20037014821 A KR20037014821 A KR 20037014821A KR 20040025919 A KR20040025919 A KR 20040025919A
- Authority
- KR
- South Korea
- Prior art keywords
- solution
- polyvinylpyrrolidone
- olopatadine
- sulfonic acid
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
제제 | 냉장-실온 주기 | 계속 저온 노출 | |||
1 주기 | 3 주기 | 7일째 | 14일째 | 28일째 | |
A | 투명,입자없음 | 투명, 약간의 입자(한 바이알) | 투명,약간의 입자 | 투명,섬유형 입자 | 투명, 입자 |
B | 투명,입자없음 | 투명, 한 바이알에서 결정(2mm) 관찰됨 | 투명, 입자 및 결정 | 투명,결정및섬유형 입자 | 투명, 결정 |
C | 투명,입자없음 | 투명, 결정 | 투명, 결정 | 투명, 결정 | 투명, 결정 |
D | 투명,많은 결정 | 투명,많은 결정 | 투명, 많은 결정 | 투명,많은 결정 | 투명, 결정 |
E | 투명,입자없음 | 투명,입자없음 | 투명,입자없음 | 투명,입자 없음 | 투명,입자 없음 |
F | 투명,입자없음 | 투명,입자없음 | 투명,입자없음 | 투명,입자 없음 | 투명,입자 없음 |
G | 투명,입자없음 | 투명, 결정 | 투명, 결정 | 투명, 결정 | 투명, 결정 |
제제 | 관찰 |
H | 시드 없이 또는 시드와 함께 두 온도에서 6 주 후 침전 없음 |
I | 두 온도 모두에서 시드와 함께 또는 시드없이 1 주기 후 흐려짐 |
J | 시드 없이 또는 시드와 함께 두 온도에서 6 주 후 침전 없음 |
제제 | 관찰 |
T | 어떤 온도에서도 침전없음 |
U | 어떤 온도에서도 침전없음 |
샘플 | 폴리비닐피롤리돈(w/w); 중량평균 분자량) | 미립자 | 섬유/무정형입자 | 투명도 |
냉장 조건(3-4℃) | ||||
9.1A | 없음 | 없음 | 섬유 | 투명 |
9.1B | 없음 | 결정 | 무정형 입자 | 흐림 |
9.2A | 0.01%(58K) | 없음 | 섬유 | 투명 |
9.2B | 0.01%(58K) | 없음 | 섬유 | 투명 |
9.3A | 0.1%(58K) | 없음 | 섬유 추정 | 투명 |
9.3B | 0.1%(58K) | 없음 | 없음 | 투명 |
9.4A | 0.2%(58K) | 없음 | 없음 | 투명 |
9.4B | 0.2%(58K) | 없음 | 없음 | 투명 |
9.5A | 0.5%(58K) | 없음 | 없음 | 투명 |
9.5B | 0.5%(58K) | 없음 | 없음 | 투명 |
9.6A | 1.0%(58K) | 없음 | 없음 | 투명 |
9.6B | 1.0%(58K) | 없음 | 없음 | 투명 |
9.7A | 0.1%(1300K) | 큰 입자 | 섬유 | 투명 |
9.7B | 0.1%(1300K) | 입자 | 섬유 | 투명 |
냉동-해동 조건(-21℃) | ||||
9.1A | 없음 | 없음 | 섬유 | 투명 |
9.1B | 없음 | 결정 | 섬유 | 투명 |
9.2A | 0.01%(58K) | 없음 | 섬유 | 투명 |
9.2B | 0.01%(58K) | 없음 | 섬유 | 투명 |
9.3A | 0.1%(58K) | 없음 | 없음 | 투명 |
9.3B | 0.1%(58K) | 없음 | 없음 | 투명 |
9.4A | 0.2%(58K) | 없음 | 없음 | 투명 |
9.4B | 0.2%(58K) | 없음 | 없음 | 투명 |
9.5A | 0.5%(58K) | 없음 | 없음 | 투명 |
9.5B | 0.5%(58K) | 없음 | 없음 | 투명 |
9.6A | 1.0%(58K) | 없음 | 없음 | 투명 |
9.6B | 1.0%(58K) | 없음 | 없음 | 투명 |
9.7A | 0.1%(1300K) | 없음 | 섬유 | 투명 |
9.7B | 0.1%(1300K) | 없음 | 섬유 | 투명 |
저장조건 | 기간/소요 시간 | 제제AB | 제제AC | 제제AD |
실온 | 1개월 | 투명 | 투명 | 투명 |
2개월 | 투명 | 투명 | 투명 | |
3개월 | 투명 | 투명 | 투명 | |
4개월 | 투명 | 투명 | 투명 | |
냉장 | 1개월 | 투명 | 투명 | 투명 |
2개월 | 투명 | 투명 | 투명 | |
3개월 | 투명 | 투명 | 투명 | |
4개월 | 투명 | 투명 | 투명 |
Claims (16)
- 0.17-0.62% 올로파타딘 및, 용액의 물리적 안정성을 향상시키는데 충분한 양의 폴리비닐피롤리돈 또는 폴리스티렌 설폰산을 필수로하여 구성된 폴리머성 물리적-안정성 향상 성분을 포함하고, 폴리비닐 알콜, 폴리비닐 아크릴 산, 히드록시프로필메틸 셀룰로스, 소듐 카복시메틸 셀룰로스 또는 잔탄 검을 함유하지 않는, 눈 및 코에서의 알레르기 또는 염증성 장애 치료용 외용 투여가능 용액 조성물.
- 제 1항에 있어서, 상기 용액은 0.18-0.22%(w/v) 올로파티딘을 포함하는 용액.
- 제 1항에 있어서, 상기 용액은 0.38-0.62%(w/v) 올로파티딘을 포함하는 용액.
- 제 1항에 있어서, 상기 용액은 5000-1,600,000의 중량 평균 분자량을 갖는 폴리비닐피롤리돈을 포함하는 용액.
- 제 4항에 있어서, 상기 용액은 50,000-60,000의 중량 평균 분자량을 갖는 폴리비닐피롤리돈을 포함하는 용액.
- 제 4항에 있어서, 상기 용액은 0.1-3%(w/v) 폴리비닐피롤리돈을 포함하는 용액.
- 제 6항에 있어서, 상기 용액은 1.5 - 2%(w/v) 폴리비닐피롤리돈을 포함하는 용액.
- 제 4항에 있어서, 상기 폴리비닐피롤리돈이 비닐피롤리돈과 비닐 아세테이트의 코폴리머인 용액.
- 제 1항에 있어서, 상기 용액은 10,000-1,500,000의 중량 평균 분자량을 갖는 폴리스티렌 설폰산을 포함하는 용액.
- 제 9항에 있어서, 상기 용액은 0.1-1%(w/v) 폴리스티렌 설폰산을 포함하는 용액.
- 제 10항에 있어서, 폴리스티렌 설폰산이 스티렌 설폰산 및 말레산 무수물의 코폴리머인 용액.
- 폴리비닐피롤리돈의 수성 용액을, 폴리비닐피롤리돈 수성 용액 내의 퍼옥사이드를 감소 또는 제거시키는데 충분한 시간 동안 실온이상의 온도에서, 올로파타딘과 폴리비닐피롤리돈을 조합시키기 이전에 처리하는 단계를 포함하는, 폴리비닐피롤리돈을 포함하는 제 1항의 용액을 제조하는 방법.
- 제 12항에 있어서, 상기 방법은 폴리비닐피롤리돈의 수성 용액을 pH 11-13에서 30-120분간 60-121℃의 온도에서, 올로파타딘과 폴리비닐피롤리돈을 조합시키기 이전에 처리하는 단계를 포함하는 방법.
- 0.17-0.25%(w/v) 올로파타딘 및, 용액의 물리적 안정성을 향상시키는데 충분한 양의 폴리비닐피롤리돈 또는 폴리스티렌 설폰산을 필수로하여 구성된 폴리머성 물리적-안정성 향상 성분을 포함하고, 폴리비닐 알콜, 폴리비닐 아크릴 산, 히드록시프로필메틸 셀룰로스, 소듐 카복시메틸 셀룰로스 또는 잔탄 검을 함유하지 않는 용액 조성물을 하루 한번 눈에 외용적으로 투여하는 것을 포함하는, 눈에서의 알레르기 또는 염증성 장애를 치료하는 방법.
- 0.17-0.62%(w/v) 올로파타딘 및, 용액의 물리적 안정성을 향상시키는데 충분한 양의 폴리비닐피롤리돈 또는 폴리스티렌 설폰산을 필수로하여 구성된 폴리머성 물리적-안정성 향상 성분을 포함하고, 폴리비닐 알콜, 폴리비닐 아크릴 산, 히드록시프로필메틸 셀룰로스, 소듐 카복시메틸 셀룰로스 또는 잔탄 검을 함유하지 않고, 3.5-8의 pH를 갖는 용액 조성물을 코에 외용적으로 투여하는 것을 포함하는, 코에서의 알레르기 또는 염증성 장애를 치료하는 방법.
- 제 15항에 있어서, 조성물이 0.62%(w/v) 올로파타딘을 포함하고 3.8-4.4의 pH를 갖는 방법.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30131501P | 2001-06-27 | 2001-06-27 | |
US60/301,315 | 2001-06-27 | ||
PCT/US2002/019417 WO2003002093A1 (en) | 2001-06-27 | 2002-06-19 | Olopatadine formulations for topical administration |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040025919A true KR20040025919A (ko) | 2004-03-26 |
KR100884711B1 KR100884711B1 (ko) | 2009-02-19 |
Family
ID=23162841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020037014821A KR100884711B1 (ko) | 2001-06-27 | 2002-06-19 | 외용 투여용 올로파타딘 제제 |
Country Status (21)
Country | Link |
---|---|
US (2) | US6995186B2 (ko) |
EP (1) | EP1399127B1 (ko) |
JP (5) | JP4827374B2 (ko) |
KR (1) | KR100884711B1 (ko) |
CN (1) | CN1211125C (ko) |
AR (1) | AR034619A1 (ko) |
AT (1) | ATE295149T1 (ko) |
AU (1) | AU2002310461B2 (ko) |
BR (1) | BRPI0210707B8 (ko) |
CA (1) | CA2447924C (ko) |
DE (1) | DE60204142T2 (ko) |
DK (1) | DK1399127T3 (ko) |
ES (1) | ES2238574T3 (ko) |
GC (1) | GC0000397A (ko) |
HK (1) | HK1059573A1 (ko) |
MX (1) | MXPA03011947A (ko) |
PL (1) | PL205565B1 (ko) |
PT (1) | PT1399127E (ko) |
TW (1) | TWI231759B (ko) |
WO (1) | WO2003002093A1 (ko) |
ZA (1) | ZA200308771B (ko) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090235933A1 (en) * | 2008-08-26 | 2009-09-24 | Trutek Corp. | Electrostatically charged mask filter products and method for increased filtration efficiency |
US20100055152A1 (en) * | 2008-08-26 | 2010-03-04 | Trutek Corporation | Antihistamine and antihistamine-like nasal application, products, and method |
US7977376B2 (en) | 2001-06-27 | 2011-07-12 | Novartis Ag | Olopatadine formulations for topical nasal administration |
TWI231759B (en) | 2001-06-27 | 2005-05-01 | Alcon Inc | Olopatadine formulations for topical administration |
US20050209312A1 (en) * | 2004-03-19 | 2005-09-22 | Bausch & Lomb Incorporated | Carboxylic acid derivatives of doxepin formulations preserved with low-irritation preservative |
KR101252863B1 (ko) * | 2004-04-08 | 2013-04-09 | 교와 핫꼬 기린 가부시키가이샤 | 안정성이 향상된 고형 제제 및 그 제조 방법 |
KR20070001232A (ko) * | 2004-04-21 | 2007-01-03 | 교와 핫꼬 고교 가부시끼가이샤 | 만성 부비강염의 예방 및/또는 치료제 |
US20050288283A1 (en) * | 2004-06-28 | 2005-12-29 | Alcon, Inc. | Topical formulations for treating allergic diseases |
CN103860540A (zh) * | 2004-11-24 | 2014-06-18 | 爱尔康公司 | 奥洛他定在治疗鼻子过敏或发炎状态的制剂制备中的用途 |
WO2006097458A1 (en) * | 2005-03-15 | 2006-09-21 | Nycomed Gmbh | Novel combination |
ES2437077T3 (es) | 2005-07-08 | 2014-01-08 | Senju Pharmaceutical Co., Ltd. | Preparado oftálmico de absorción percutánea que comprende olopatadina |
US20070077302A1 (en) * | 2005-09-30 | 2007-04-05 | Azaam Alli | Methods for stabilizing ophthalmic compositions |
AR063621A1 (es) | 2006-11-09 | 2009-02-04 | Alcon Res Ltd | Matriz polimerica insoluble en agua para la administracion de farmacos |
US20080114076A1 (en) * | 2006-11-09 | 2008-05-15 | Alcon Manufacturing Ltd. | Punctal plug comprising a water-insoluble polymeric matrix |
TW200829293A (en) * | 2006-12-18 | 2008-07-16 | Alcon Mfg Ltd | Devices and methods for ophthalmic drug delivery |
WO2008093358A2 (en) * | 2007-01-29 | 2008-08-07 | Sun Pharmaceutical Industries Limited | Aqueous topical solution containing olopatadine |
ES2781090T3 (es) * | 2007-02-07 | 2020-08-28 | Novartis Ag | Formulaciones de olopatadina para administración nasal tópica |
WO2008120249A1 (en) * | 2007-03-30 | 2008-10-09 | Sifi S.P.A. | Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use |
JP2010523695A (ja) * | 2007-04-11 | 2010-07-15 | アルコン リサーチ, リミテッド | アレルギー性鼻炎およびアレルギー性結膜炎を処置するためのTNFαのインヒビターおよび抗ヒスタミン薬の使用 |
US20100227917A1 (en) * | 2007-09-06 | 2010-09-09 | Masashi Nakakura | EYE DROP CONTAINING DIBENZ[b,e]OXEPIN DERIVATIVE |
CA2723954A1 (en) * | 2008-05-19 | 2009-11-26 | Alcon Research, Ltd. | Pharmaceutical compositions having carboxyvinyl polymer and povidone polymer |
KR20110056526A (ko) * | 2008-08-28 | 2011-05-30 | 트루텍 코프. | 항히스타민 및 유사-항히스타민 코 외용약, 생성물 및 방법 |
US9458198B1 (en) | 2009-06-26 | 2016-10-04 | Shire Orphan Therapies Gmbh | Cyclic peptide-based NPR-B agonists |
MX2012000539A (es) * | 2009-07-17 | 2012-02-28 | Alcon Res Ltd | Regimen de rocio nasal de olopatadina para niños. |
WO2011027322A1 (en) * | 2009-09-03 | 2011-03-10 | Ranbaxy Laboratories Limited | Extended release dosage form containing olopatadine for oral administration |
US8551938B2 (en) * | 2009-09-25 | 2013-10-08 | Alcon Research, Ltd. | NPR-B agonists |
KR101854820B1 (ko) | 2009-09-25 | 2018-05-04 | 샤이어 오펀 테라피즈 게엠베하 | 신규한 npr-b 길항제 |
MX2012003693A (es) * | 2009-10-01 | 2012-04-19 | Alcon Res Ltd | Composiciones de olopatadine y usos de las mismas. |
AR078446A1 (es) | 2009-12-18 | 2011-11-09 | Alcon Res Ltd | Agonistas de npr-b. uso. |
WO2011075471A2 (en) | 2009-12-18 | 2011-06-23 | Alcon Research, Ltd. | Novel npr-b agonists and methods of use for the treatment of c-type natriuretic peptide-mediated disorders |
JP2013535451A (ja) * | 2010-07-21 | 2013-09-12 | アルコン リサーチ, リミテッド | 増強された溶解度特徴を有する薬学的組成物 |
AU2011327785A1 (en) * | 2010-11-08 | 2013-03-07 | Healor Ltd. | Buffered ophthalmic compositions and methods of use thereof |
TWI544922B (zh) | 2011-05-19 | 2016-08-11 | 愛爾康研究有限公司 | 高濃度歐羅派特錠(olopatadine)眼用組成物 |
CN102885767A (zh) * | 2012-11-02 | 2013-01-23 | 江苏吉贝尔药业有限公司 | 一种新的盐酸奥洛他定滴眼液及其制备方法 |
EP3576770A1 (en) | 2017-02-01 | 2019-12-11 | Shire Human Genetic Therapies, Inc. | Compounds and compositions for the treatment of ophthalmic disorders |
JP7037349B2 (ja) * | 2017-06-23 | 2022-03-16 | 参天製薬株式会社 | 水溶性粘稠化剤を含有する医薬組成物 |
WO2018235935A1 (ja) * | 2017-06-23 | 2018-12-27 | 参天製薬株式会社 | 水溶性粘稠化剤を含有する医薬組成物 |
CA3160570A1 (en) * | 2019-12-06 | 2021-06-10 | Taizou Kamishita | Rhinenchysis composition containing olopatadine |
CN111700860A (zh) * | 2020-07-09 | 2020-09-25 | 浙江尖峰药业有限公司 | 盐酸奥洛他定滴眼液及其制备方法 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4370324A (en) | 1980-09-17 | 1983-01-25 | Bernstein Joel E | Method and composition for treating and preventing irritation of the eyes |
US4407791A (en) * | 1981-09-28 | 1983-10-04 | Alcon Laboratories, Inc. | Ophthalmic solutions |
US4749700A (en) * | 1984-10-23 | 1988-06-07 | Nastech Pharmaceutical Co, Inc. | Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same |
GB8520662D0 (en) * | 1985-08-17 | 1985-09-25 | Wellcome Found | Tricyclic aromatic compounds |
US4923892A (en) * | 1985-08-17 | 1990-05-08 | Burroughs Wellcome Co. | Tricyclic aromatic compounds |
JPS6310784A (ja) | 1986-03-03 | 1988-01-18 | Kyowa Hakko Kogyo Co Ltd | 抗アレルギー剤 |
DE3877904D1 (de) * | 1987-11-13 | 1993-03-11 | Asta Pharma Ag | Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge. |
IT1250691B (it) * | 1991-07-22 | 1995-04-21 | Giancarlo Santus | Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac. |
JP3662944B2 (ja) | 1993-08-24 | 2005-06-22 | 協和醗酵工業株式会社 | 点鼻剤 |
US5897858A (en) * | 1994-02-03 | 1999-04-27 | Schering-Plough Healthcare Products, Inc. | Nasal spray compositions exhibiting increased retention in the nasal cavity |
US5641805A (en) * | 1995-06-06 | 1997-06-24 | Alcon Laboratories, Inc. | Topical ophthalmic formulations for treating allergic eye diseases |
WO1998056381A1 (en) * | 1997-06-09 | 1998-12-17 | Bridge Pharma, Inc. | Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use |
KR100598723B1 (ko) | 1998-07-14 | 2006-07-11 | 알콘 매뉴팩츄어링, 리미티드 | 비알레르기성 안염증 질환 치료 및 안혈관신생 예방용약제를 제조하기 위한11-(3-디메틸아미노프로필리덴)-6,11-디하이드로디벤즈[β,ε]옥세핀-2-아세트산의 용도 |
US6146622A (en) | 1998-10-27 | 2000-11-14 | Alcon Laboratories, Inc. | Use of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions |
PT1124535E (pt) * | 1998-10-27 | 2003-04-30 | Alcon Lab Inc | Sistema conservante para composicoes farmaceuticas topicamente administraveis contendo um sabao de acido gordo/amino acido |
US6274626B1 (en) * | 1998-12-22 | 2001-08-14 | Bausch & Lomb Incorporated | Pheniramine-containing compositions and method for treating allergic responses |
US6174914B1 (en) * | 1999-06-15 | 2001-01-16 | Alcon Laboratories, Inc. | Method of inhibiting cytokine release from human ocular cells |
PL354365A1 (en) | 1999-09-21 | 2004-01-12 | Alcon Laboratories, Inc. | Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions |
BR0015647A (pt) | 1999-11-18 | 2002-07-16 | Alcon Inc | Uso de um antagonista de h1 e um esteróide seguro para tratar condições dos olhos |
ATE291913T1 (de) | 2000-01-25 | 2005-04-15 | Alcon Inc | Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen |
PE20020578A1 (es) | 2000-10-10 | 2002-08-14 | Upjohn Co | Una composicion de antibiotico topico para el tratamiento de infecciones oculares |
TWI231759B (en) | 2001-06-27 | 2005-05-01 | Alcon Inc | Olopatadine formulations for topical administration |
MXPA05005044A (es) | 2002-11-12 | 2005-07-01 | Alcon Inc | El uso de un agente antialergico y un esteroide para tratar rinitis alergica. |
-
2002
- 2002-06-18 TW TW091113234A patent/TWI231759B/zh not_active IP Right Cessation
- 2002-06-19 KR KR1020037014821A patent/KR100884711B1/ko active IP Right Grant
- 2002-06-19 AT AT02737539T patent/ATE295149T1/de active
- 2002-06-19 MX MXPA03011947A patent/MXPA03011947A/es active IP Right Grant
- 2002-06-19 EP EP02737539A patent/EP1399127B1/en not_active Expired - Lifetime
- 2002-06-19 CN CNB028120434A patent/CN1211125C/zh not_active Expired - Lifetime
- 2002-06-19 PL PL367780A patent/PL205565B1/pl unknown
- 2002-06-19 ES ES02737539T patent/ES2238574T3/es not_active Expired - Lifetime
- 2002-06-19 DE DE60204142T patent/DE60204142T2/de not_active Expired - Lifetime
- 2002-06-19 PT PT02737539T patent/PT1399127E/pt unknown
- 2002-06-19 CA CA002447924A patent/CA2447924C/en not_active Expired - Lifetime
- 2002-06-19 DK DK02737539T patent/DK1399127T3/da active
- 2002-06-19 BR BRPI0210707A patent/BRPI0210707B8/pt not_active IP Right Cessation
- 2002-06-19 AU AU2002310461A patent/AU2002310461B2/en not_active Expired
- 2002-06-19 WO PCT/US2002/019417 patent/WO2003002093A1/en active IP Right Grant
- 2002-06-19 US US10/175,106 patent/US6995186B2/en not_active Expired - Lifetime
- 2002-06-19 JP JP2003508332A patent/JP4827374B2/ja not_active Expired - Lifetime
- 2002-06-22 GC GCP20022092 patent/GC0000397A/en active
- 2002-06-24 AR ARP020102365A patent/AR034619A1/es not_active Application Discontinuation
-
2003
- 2003-11-11 ZA ZA2003/08771A patent/ZA200308771B/en unknown
-
2004
- 2004-04-06 HK HK04102452A patent/HK1059573A1/xx not_active IP Right Cessation
-
2005
- 2005-03-15 US US11/079,996 patent/US7402609B2/en not_active Expired - Lifetime
-
2009
- 2009-03-02 JP JP2009048628A patent/JP2009114213A/ja not_active Withdrawn
-
2010
- 2010-03-24 JP JP2010069010A patent/JP2010150292A/ja not_active Withdrawn
-
2012
- 2012-02-21 JP JP2012035170A patent/JP5328947B2/ja not_active Expired - Lifetime
-
2013
- 2013-03-25 JP JP2013061887A patent/JP2013127005A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100884711B1 (ko) | 외용 투여용 올로파타딘 제제 | |
AU2002310461A1 (en) | Olopatadine formulations for topical administation | |
US9308173B2 (en) | Slow-releasing ophthalmic compositions comprising povidone iodine | |
EP0925789B1 (en) | Use of azithromycin in the topical treatment of ocular infections | |
EP0824916B1 (en) | Pranoprofen eyedrops containing organic amine | |
US6861411B1 (en) | Method of treating eye infections with azithromycin | |
WO2001047521A1 (en) | Use of ketotifen as ophthalmic agent | |
US9801813B2 (en) | Preservative-free ophthalmic pharmaceutical formulation | |
MXPA98010124A (en) | Procedure to treat ocular infections with azitromic | |
JP2009509993A (ja) | ヘルペス性角膜炎の治療のためのブリブジンを含む光安定性医薬品成物 | |
AU2010236505B2 (en) | Aqueous ophthalmic compositions containing anionic therapeutic agents | |
JPH03106816A (ja) | 緑内障治療用点眼剤 | |
RU2100020C1 (ru) | Средство для местного лечения глазной гипертензии и глаукомы и способ его получения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130117 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20140121 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20150119 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20160119 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20170201 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20180201 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20190129 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20200129 Year of fee payment: 12 |